Influvac Tetra

Don’t wait - VACCINATE

For Influenza

Influvac Tetra more power with Broad protection

Book your now

+91

This information shall be shared with Abbott India Limited (“Abbott”), for processing this request. You hereby give your consent to Abbott for usage of your personal information collected as part of this order booking as per Abbott Privacy Policy-India available on the link at https://www.abbott.co.in/privacy-policy.html

Now available with LATEST NH 2023-2024 STRAIN as recommended by WHO

Subunit quadrivalent Influenza vaccine with less impurities^4,5,6,7

80%-90% seroprotection with least reactogenicity ⁸

Prefilled syringe, ready to use and convenient ⁷

References:

1. Macias A E et al. The disease burden of influenza beyond respiratory illness. Vaccine 2021;39;1:A6-A14
2. Fang Y A et al. Influenza Vaccination Reduces Hospitalization for Heart Failure in Elderly Patients with Chronic Kidney Disease: A Population-Based Cohort Study. Acta Cardiol Sin. 2016 May; 32(3): 290–298.
3. World Health Organization (WHO). Background Paper on Influenza Vaccines and Immunization. SAGE Working Group [Internet] [Cited 2019 Aug 2]. Available at: https://www.who.int/immunization/sage/meetings/2012/april/1 Background_Paper_Mar26_v13_cleaned.pdf.
4. Centers for Disease Control and Prevention. Quadrivalent Influenza Vaccine. [Internet] [Updated 2019 Nov 6] [Cited 2023 Jan 16]. Available at: https://www.cdc.gov/flu/prevent/quadrivalent.htm.
5. Shah R et al. Advantages of Subunit Influenza Vaccine: An Overall Perspective. AJPP. 2018; 1(5): 19-28.
6. Wood JM, Williams MS. History of inactivated Influenza vaccines. In: textbook of influenza. Oxford: Blackwell Science 1998, pp. 317-323.
7. Influvac Tetra PI, Data on file
8. Zuccotti GV, Fabiano V. Influvac, a trivalent inactivated subunit influenza vaccine. Expert Opin Bial Ther 2011;11(1):89-98.

WHO RECOMMENDS